Institute of Materia Medica and TB Alliance Announce Partnership to Develop New Tuberculosis Drugs
Beijing and New York, January 31, 2007 – The Institute of Materia Medica (IMM), a member of the Chinese Academy
Beijing and New York, January 31, 2007 – The Institute of Materia Medica (IMM), a member of the Chinese Academy
TB Alliance Board of Directors Appoints Three New Members New Stakeholders Association President Joins Board as Member Ex Officio For
PARIS (Nov. 2, 2006) – Responding to a tuberculosis (TB) pandemic that is growing more threatening and deadly, the Dutch
NEW YORK (Oct. 12, 2006) – The Global Alliance for TB Drug Development (TB Alliance) announced today that it has
FOR IMMEDIATE RELEASE Global Alliance for TB Drug Development Applauds Innovative, International Effort to Fund New Drugs ‘UNITAID’ Announces Funding
Licensing Executive Society Awards the “Deal of Distinction” Prize for Top Licensing Agreement in the Industry-University-Government Category NEW YORK CITY
TB Alliance Applauds Actions by Health Leaders on XDR-TB and Says More Resources are Needed to Speed Development of New
The TB Alliance announced on May 25 that it is receiving $104 million from the Bill & Melinda Gates Foundation
Three Grants Announced at Columbia University Symposium Tracking Progress in Battle Against Disease Infecting One-Third of the World NEW YORK
Project Aims to Streamline and Shorten Drug Development for Tuberculosis New York, NY and Waltham, MA., February 21, 2006 –